Sanofi unions denounce new job cuts

The Sanofi site in Vitry-sur-Seine, in the Paris region.

© REUTERS - CHARLES PLATIAU

Text by: RFI Follow

2 min

In the race for vaccine production, Sanofi continues to cut its workforce in Europe.

The unions denounce today a new project of 424 job cuts on the continent.

But at the same time, the French pharmaceutical giant is investing heavily in the rest of the world. 

Publicity

Read more

Croatia, Serbia, Bosnia, Bulgaria, the Baltic countries or even Cyprus.

A total of 14 countries, mainly in eastern Europe, would be affected by the new job cuts at Sanofi.

According to the unions of the pharmaceutical giant, 424 new positions will be cut in the commercial branches of the group.

This restructuring, if confirmed by management, would be added to the

announcements of

last

June

: loss of 1,700 jobs in Europe, including a thousand in France. 

Sanofi downsizes and on the same day announces that it will invest 400 million euros to build an innovative vaccine plant in Singapore to supply the Asian market.

At the end of March, we also learned that an influenza vaccine plant was going to be built near Toronto in Canada.

Cost of the operation for the group: $ 455 million.

For the

unions

, this strategy of "double standards" simply risks impoverishing the European health system.

But above all, it is irresponsible, according to them, in the midst of the Covid-19 pandemic.

As we recall, the French group will not put a

vaccine on the market

 before the end of the year, at the earliest.  

Newsletter

Receive all international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application

google-play-badge_FR

  • Industry

  • Trade and exchanges

  • Employment and Work

  • Unions